Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

InspireMD Inc

NSPR
Current price
2.51 USD +0.39 USD (+18.40%)
Last closed 2.39 USD
ISIN US45779A8466
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 58 611 276 USD
Yield for 12 month -15.77 %
1Y
3Y
5Y
10Y
15Y
NSPR
21.11.2021 - 28.11.2021

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel. Address: 4 Menorat Hamaor Street, Tel Aviv, Israel, 6744832

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.5 USD

P/E ratio

Dividend Yield

Current Year

+6 205 000 USD

Last Year

+5 171 000 USD

Current Quarter

+1 739 000 USD

Last Quarter

+1 511 000 USD

Current Year

+1 807 000 USD

Last Year

+1 117 000 USD

Current Quarter

+331 000 USD

Last Quarter

+292 000 USD

Key Figures NSPR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -26 867 000 USD
Operating Margin TTM -474.99 %
PE Ratio
Return On Assets TTM -31.02 %
PEG Ratio
Return On Equity TTM -54.55 %
Wall Street Target Price 4.5 USD
Revenue TTM 6 567 000 USD
Book Value 1.86 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 5.5 %
Dividend Yield
Gross Profit TTM 1 117 000 USD
Earnings per share -0.61 USD
Diluted Eps TTM -0.61 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics NSPR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History NSPR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 27.04.2021
Dividend Date 01.04.2019

Stock Valuation NSPR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 11.6959
Enterprise Value Revenue 1.9449
Price Sales TTM 8.9251
Enterprise Value EBITDA 0.5151
Price Book MRQ 1.2534

Financials NSPR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NSPR

For 52 weeks

1.81 USD 3.42 USD
50 Day MA 2.6 USD
Shares Short Prior Month 43 453
200 Day MA 2.55 USD
Short Ratio 2.19
Shares Short 44 000
Short Percent 0.23 %